Skip to product information
1 of 1

Global Vet & Co

The Laboratory Rat 3Rd Edition

The Laboratory Rat 3Rd Edition

Regular price HK$210.00
Regular price HK$840.00 Sale price HK$210.00
Sale Sold out
Quantity
Instant PDF download
PDF & EPUB included
Secure checkout
7-day refund policy

Master The Laboratory Rat 3Rd Edition with this comprehensive guide. Essential reading for veterinary students, practitioners, and technicians seeking to deepen their expertise in Animals Books > Lab Animals > The Laboratory Rat 3rd Edition. Includes clinical case studies and practical applications. Instant digital download.

Table of Contents

  • Contents (p.6)
  • Contributors (p.12)
  • Preface (p.16)
  • 1 - Historical Foundations (p.22)
  • References (p.60)
  • 2 - Taxonomy and Stocks and Strains (p.66)
  • 1 Standard Inbred Strains (p.72)
  • 2 Coisogenic and Congenic Strains (p.72)
  • 3 Consomic or Chromosome Substitution Strains (p.86)
  • 4 Conplastic Strains (p.86)
  • 5 Recombinant Inbred Strains (p.87)
  • 6 Genetically Modified Rats (p.87)
  • 1 Standard Inbred Strains (p.89)
  • 2 F1 Hybrids (p.90)
  • 3 Coisogenic Strains (p.90)
  • 4 Congenic Strains (p.90)
  • 4 Consomic Strains (p.90)
  • 5 Conplastic Strains (p.90)
  • 6 Recombinant Inbred Strains (p.90)
  • 7 Genetically Modified Rats (p.90)
  • References (p.91)
  • 3 - Translational Potential of Rats in Research (p.96)
  • References (p.102)
  • 4 - Functional Anatomy and Physiology (p.110)
  • 1 Sight and the Eye (p.115)
  • 2 Olfaction (p.119)
  • 3 Taste (p.120)
  • 4 Hearing and Vestibular Function (p.120)
  • 5 Touch (p.121)
  • References (p.141)
  • 5 - Clinical Pathology of the Rat (p.152)
  • 1 Anemia of Chronic Disease (p.159)
  • 2 Immune-Mediated Hemolytic Destruction/Removal of Red Blood Cells (p.159)
  • 3 Oxidant Injury (p.160)
  • 4 Plasmodium berghei-Induced Anemia (p.160)
  • 5 Hereditary Anemias (p.160)
  • 6 Howell–Jolly Bodies (p.160)
  • 7 Poikilocytosis (p.160)
  • 1 Hepatocellular Disease (p.161)
  • 2 Cholestatic/Hepatobiliary Disease (p.161)
  • 3 Inherited Models of Hyperbilirubinemia (p.161)
  • 4 Hepatocellular Hypertrophy (p.161)
  • 5 Emerging Biomarkers of Liver Injury (p.162)
  • References (p.168)
  • 6 - Reproduction and Breeding (p.176)
  • 1 Cycle Description (p.177)
  • 2 Estrous Cycle Stage Identification (p.178)
  • 3 Estrous Synchronization (p.179)
  • 1 Breeding (p.187)
  • 2 Inbred Strains (p.190)
  • 3 Outbred Stocks (p.190)
  • 4 Consideration for Genetically Manipulated Lines (p.191)
  • 1 Animal Identification (p.191)
  • 2 Record-Keeping Tools (p.191)
  • 3 Colony Record-Keeping Requirements (p.194)
  • References (p.194)
  • 7 - Assisted Reproductive Technologies and Genetic Modifications in Rats (p.200)
  • 1 Recovery from Female Rats (p.201)
  • 2 Recovery from Male Rats (p.203)
  • 1 In Vitro Fertilization (p.205)
  • 2 Micro-insemination (p.206)
  • 3 Artificial Insemination (p.207)
  • 4 In Vitro Embryo Culture (p.207)
  • 1 Vasectomy (p.208)
  • 2 Establishment of Pseudopregnant Females (p.208)
  • 3 Recipient Synchronization (p.209)
  • 4 Surgical Embryo Transfer (p.209)
  • 5 Nonsurgical Embryo Transfer (p.209)
  • 1 Pronuclear Injection (p.214)
  • 2 Transposition-Mediated Gene Delivery (p.215)
  • 3 Viral Vector–Mediated Gene Delivery (p.216)
  • 4 Sperm-Mediated Gene Delivery via Intracytoplasmic Sperm Injection (p.217)
  • 5 Spermatogonial Stem Cell-Mediated Gene Delivery (p.217)
  • 1 Embryonic Stem Cell Technology (p.217)
  • 2 N-Ethyl-N-nitrosourea-Induced Mutagenesis (p.219)
  • 3 Somatic Cell Nuclear Transfer (p.220)
  • 4 Gene Knockout Technologies (p.222)
  • 5 Novel Gene Editing Technologies by Endonucleases (p.223)
  • References (p.226)
  • 8 - Analysis of Behavior in Laboratory Rats1 (p.234)
  • 1 Example of Video-Based Behavioral Analysis (p.236)
  • References (p.257)
  • 9 - Nutrition (p.262)
  • 1 Macrominerals (p.274)
  • 2 Microminerals (p.281)
  • 1 Fat-Soluble Vitamins (p.295)
  • 2 Water-Soluble Vitamins (p.299)
  • 1 Meal Feeding (p.319)
  • 2 Pair Feeding (p.319)
  • 1 Fructose Feeding (p.322)
  • 2 High-Fat Diets (p.323)
  • 3 Very High-Fat Diets (p.323)
  • 4 High-Fat and High-Sugar Diets (p.323)
  • 5 Metabolic Syndrome Control Diets (p.324)
  • References (p.334)
  • 10 - Housing and Environment (p.368)
  • 1 Isolation Caging (p.374)
  • 1 Individual Versus Group Housing (p.379)
  • References (p.416)
  • 11 - Medical Management and Diagnostic Approaches (p.440)
  • 1 Random Testing of Resident Animals (p.444)
  • 2 Targeted Sentinel Programs (p.445)
  • 3 Vendor Screening (p.447)
  • 4 Quarantine (p.447)
  • 5 Screening of Imported Biological Materials (p.448)
  • 1 General Test Performance Guidelines (p.449)
  • 2 Testing Methodologies (p.450)
  • 3 Tissue Preparation (p.457)
  • 4 Interfacing the Rat Necropsy With the Microscopic Evaluation of Tissues (p.458)
  • 5 Screening of Tissue by Histology for Lesions of Infectious Disease (p.458)
  • References (p.466)
  • 12 - Bacterial, Mycoplasmal, and Mycotic Infections (p.470)
  • 1 Streptococcus pneumoniae (p.482)
  • 2 The β-Hemolytic Streptococci (p.484)
  • 3 Enterococcus sp. Infection (p.485)
  • 1 Rodentibacter pneumotropicus, Rodentibacter heylii (syn. Pasteurella pneumotropica) (p.509)
  • 2 Muribacter muris (Actinobacillus muris) (p.512)
  • 3 Rodentibacter heidelbergensis and Rodentibacter trehalosifermentans (Haemophilus) (p.513)
  • 1 Klebsiella pneumoniae and Klebsiella oxytoca (p.514)
  • 2 Bordetella bronchiseptica (p.515)
  • 3 Staphylococcus aureus (p.516)
  • 1 Mycoplasma neurolyticum (p.522)
  • 2 Mycoplasma volis (p.522)
  • References (p.531)
  • 13 - Viral Disease (p.560)
  • 1 Clinical Signs (p.562)
  • 2 Epidemiology (p.563)
  • 3 Pathology and Pathogenesis (p.564)
  • 4 Diagnosis (p.566)
  • 5 Control and Prevention (p.566)
  • 6 Interference with Research (p.566)
  • 1 Clinical Signs (p.569)
  • 2 Epidemiology (p.569)
  • 3 Pathology and Pathogenesis (p.570)
  • 4 Diagnosis (p.572)
  • 5 Differential Diagnosis (p.572)
  • 6 Control and Prevention (p.572)
  • 7 Interference with Research (p.573)
  • 8 Rat Coronavirus as a Model of Respiratory Viral Infection (p.573)
  • 9 Emergence of Novel Rat Coronaviruses (p.573)
  • 1 Sendai Virus (p.575)
  • 2 Other Paramyxoviruses (p.577)
  • 1 Cardioviruses (p.577)
  • 2 Other Picornaviruses (p.578)
  • 1 Reovirus (p.578)
  • 2 Rotavirus (p.578)
  • References (p.579)
  • 14 - Parasitic Diseases (p.588)
  • 1 Trypanosoma lewisi (p.589)
  • 1 Hepatozoon muris (p.590)
  • 2 Toxoplasma gondii (p.590)
  • 3 Hammondia hammondi (p.592)
  • 4 Sarcocystis spp. (p.592)
  • 5 Frenkelia spp. (p.593)
  • 1 Trichinella spiralis (p.593)
  • 2 Calodium hepaticum (p.594)
  • 3 Trichosomoides crassicauda (p.596)
  • 4 Gongylonema neoplasticum (p.597)
  • 1 Taenia taeniaeformis (Cysticercus fasciolaris) (p.597)
  • 1 Giardia muris (p.598)
  • 2 Spironucleus (Hexamita) muris (p.599)
  • 3 Hexamastix muris (p.599)
  • 4 Chilomastix bettencourti (p.600)
  • 5 Tritrichomonas muris (p.600)
  • 6 Tritrichomonas minuta (p.600)
  • 7 Tetratrichomonas microti (p.600)
  • 8 Pentatrichomonas hominis (p.600)
  • 1 Eimeria nieschulzi (p.600)
  • 2 Eimeria spp. (p.601)
  • 1 Entamoeba muris (p.601)
  • 1 Balantidium coli (p.601)
  • 1 Syphacia muris (p.602)
  • 2 Syphacia obvelata (p.604)
  • 3 Aspiculuris tetraptera (p.604)
  • 4 Heterakis spumosa (p.605)
  • 1 Rodentolepis nana (p.605)
  • 2 Hymenolepis diminuta (p.606)
  • 1 Polyplax spinulosa (p.607)
  • 1 Radfordia ensifera (p.608)
  • 2 Notoedres muris (p.608)
  • 3 Mesostigmatid Mites (p.609)
  • References (p.612)
  • 15 - Neoplastic Disease (p.620)
  • 1 Adrenal Cortex (p.647)
  • 2 Adrenal Medulla (p.647)
  • References (p.661)
  • 16 - Metabolic, Traumatic, and Miscellaneous Diseases (p.670)
  • References (p.703)
  • 17 - Anesthesia, Analgesia, and Euthanasia (p.718)
  • 1 Duration of Anesthesia (p.718)
  • 2 Procedure Invasiveness and Pain Potential (p.718)
  • 3 Training and Expertise (p.719)
  • 4 Age and Concurrent Disease (p.719)
  • 5 Experimental Constraints (p.719)
  • 1 Health Status (p.719)
  • 2 Fasting (p.720)
  • 3 Preanesthetic Drugs (p.720)
  • 4 Medical Records (p.720)
  • 1 Anesthesia Recovery (p.720)
  • 1 Anticholinergics (p.724)
  • 2 Sedatives and Tranquilizers (p.724)
  • 1 Anesthesia Machines (p.726)
  • 2 Ancillary Equipment (p.726)
  • 3 Waste Gas Scavenging (p.727)
  • 4 Endotracheal Intubation (p.728)
  • 1 Pentobarbital (p.732)
  • 2 Thiopental (p.732)
  • 3 Methohexital (p.733)
  • 4 Thiobutabarbital (Inactin) (p.733)
  • 1 Ketamine (p.733)
  • 2 Tiletamine/Zolazepam (p.734)
  • 1 α-Chloralose (p.736)
  • 2 Alphaxalone/Alphadolone (Saffan, Althesin) (p.736)
  • 3 Chloral Hydrate (p.737)
  • 4 Propofol (p.737)
  • 5 Tribromoethanol (p.737)
  • 6 Urethane (Ethyl Carbamate) (p.737)
  • 1 Opioids (p.742)
  • 2 Nonsteroidal Antiinflammatory Drugs (p.745)
  • 3 Local Anesthetics (p.747)
  • 4 Miscellaneous Drugs (p.748)
  • 1 Physical Methods (p.749)
  • 2 Injectable Methods (p.751)
  • 3 Inhalation Methods (p.751)
  • 4 Volatile Anesthetics (p.753)
  • 5 Neonates/Fetal Animals (p.753)
  • 6 Unacceptable Methods (p.754)
  • 7 Practicalities That Apply to all Methods (p.754)
  • 8 Summary/Conclusion (p.754)
  • References (p.754)
  • 18 - Care of Surgical and Other Fragile Models (p.766)
  • 1 Health Status (p.766)
  • 2 Medical Records (p.766)
  • 3 Fasting (p.767)
  • 4 Preanesthetic Drugs (p.767)
  • 5 Surgical Preparation and Asepsis (p.767)
  • 1 Monitoring (p.769)
  • 2 Intraoperative Support (p.771)
  • 1 Anesthesia Recovery (p.772)
  • 2 Surgical Recovery (p.773)
  • 1 Dilated Cardiomyopathy (p.776)
  • 2 Hypertension and Stroke (p.776)
  • 3 Myocardial Infarction (p.777)
  • 1 Diabetes Mellitus and Metabolic Syndrome (p.777)
  • 2 Hypoadrenocorticism (p.777)
  • 3 Hypothyroidism/Hypoparathyroidism (p.778)
  • 4 Osteoporosis (p.778)
  • 1 Rheumatoid Arthritis (p.779)
  • 1 Neurodegenerative Disease (p.779)
  • 2 Spinal Cord and Peripheral Nerve Injury (p.780)
  • 1 Cranial Implants (p.782)
  • 2 Chronic Indwelling Catheters and Vascular Access Ports (p.782)
  • 3 Osmotic Pumps (p.783)
  • 4 Telemetry Devices (p.783)
  • References (p.783)
  • 19 - General Experimental Techniques (p.790)
  • 1 Cardiac Puncture (p.796)
  • 2 Orbital Plexus (p.796)
  • 3 Dorsal Metatarsal Vein (p.797)
  • 4 Saphenous Vein (p.798)
  • 5 Tail Vein (p.798)
  • 6 Jugular Vein (p.799)
  • 7 Carotid Artery (p.800)
  • 8 Decapitation (p.800)
  • 9 Other Techniques (p.801)
  • 1 Manual Expression and Free Catch (p.801)
  • 2 Cystocentesis (p.801)
  • 3 Catheterization, Cystotomy, and Cannulation (p.801)
  • 4 Other Methods (p.802)
  • 1 Ova and Embryos (p.806)
  • 2 Vaginal Fluids and Cells (p.806)
  • 3 Milk (p.807)
  • 1 Direct Collection (p.809)
  • 2 Cannulation Techniques (p.810)
  • 3 Removal of Salivary Glands at Necropsy (p.810)
  • 1 Gavage (p.810)
  • 2 Pilling (p.811)
  • 3 Surgical Cannulation (p.811)
  • 4 Syringe Feeding (p.811)
  • 5 Medicated Diets or Food Treats (p.811)
  • 6 Administration in Drinking Water (p.812)
  • 1 Lateral Tail Vein (p.812)
  • 2 Infusion via Chronic Indwelling Catheters (p.812)
  • 3 Lingual Vein (p.813)
  • 4 Dorsal Vein of the Penis (p.813)
  • 5 Other Intravenous Injection Techniques (p.814)
  • 1 Blood Pressure Determination (p.816)
  • 2 Blood and Plasma Volume Determination (p.816)
  • 3 Electrocardiographic Techniques (p.817)
  • 1 Electroencephalography (p.817)
  • 2 Peripheral Nerve Conduction Velocity (p.817)
  • 3 Evoked Potentials (p.817)
  • 4 Brain Imaging (p.818)
  • References (p.819)
  • 20 - Integrating Biology With Rat Genomic Tools (p.830)
  • 1 PhenoMiner (p.838)
  • 2 OLGA (p.838)
  • 3 Variant Visualizer (p.838)
  • 4 Pathways (p.838)
  • References (p.840)
  • 21 - Gnotobiotics and the Microbiome (p.846)
  • 1 LOBUND (p.856)
  • 2 Karolinska Institutet (p.857)
  • 3 University of Wisconsin (p.857)
  • 4 Commercial Suppliers (p.857)
  • 5 Others (p.857)
  • 1 Colon Cancer (p.858)
  • 2 Breast and Prostate Cancers (p.858)
  • 3 Leukemia (p.858)
  • 4 Urethral Cancer (p.858)
  • 5 Endocrine Cancer (p.858)
  • References (p.862)
  • 22 - Toxicology (p.868)
  • References (p.879)
  • 23 - Embryology and Teratology (p.882)
  • 1 Fertilization (p.882)
  • 2 Cleavage/Morula Formation (p.883)
  • 3 Blastocyst (p.884)
  • 4 Yolk Sac Placenta Development (p.885)
  • 1 Neurulation and Early Central Nervous System Development (p.888)
  • 2 Somite Formation (p.890)
  • 3 Cardiovascular System (p.890)
  • 4 Urogenital System (p.893)
  • 5 Craniofacial Development (p.894)
  • 6 Limb Development (p.896)
  • 1 Dose Selection (p.899)
  • 2 Routes of Administration, Frequency of Dosing, and Dose Volume (p.899)
  • 3 In Vivo Observations (p.900)
  • 4 Toxicokinetic Parameters (p.900)
  • 5 Dam Necropsy and Collection of Fetal and Placental Data (p.900)
  • 6 Fetal Evaluations (p.901)
  • 7 Evaluation Criteria (p.902)
  • 8 Statistical Analysis (p.903)
  • References (p.904)
  • 24 - Rat Immunology (p.910)
  • 1 Organs and Tissues of the Rat's Immune System (p.912)
  • 2 Cells and Intercellular Messengers of the Rat's Immune System (p.915)
  • 3 Intersections Between Adaptive and Innate Immunity (p.920)
  • 1 Biobreeding Diabetes-Prone Rats (BBDP) (p.923)
  • 2 Long-Evans Cinnamon Rats (LEC) (p.923)
  • 3 Brown Norway Rats (BN) (p.923)
  • 4 Lewis Rats (LEW) (p.924)
  • 5 Athymic Nude Rat (p.924)
  • 6 IL12g-deficient and F344-SCID gamma Rats (p.924)
  • 7 Humanized Immune System Rats (p.925)
  • 1 Cardiac Transplantation (p.925)
  • 2 Kidney Transplantation (p.927)
  • 3 Liver Transplantation (p.929)
  • 4 Lung Transplantation (p.931)
  • 5 Vascularized Composite Allografts (p.931)
  • References (p.932)
  • 25 - Cardiovascular Research (p.946)
  • 1 Myocyte Orientation (p.950)
  • 2 Cellular Composition (p.951)
  • 3 Myocyte Dimensions (p.951)
  • 4 Myocyte Structural Changes During Growth (p.952)
  • 1 Historical Development (p.958)
  • 2 Hypertension and Complicating Lesions (p.958)
  • 3 Mechanism of Hypertension in Spontaneously Hypertensive Rats (p.960)
  • 4 Pathogenesis of Hypertrophy (p.960)
  • 1 Spontaneously Hypertensive Stroke Prone Rats (p.960)
  • 2 Spontaneously Hypertensive Obese Rats (p.961)
  • 3 Spontaneously Hypertensive Heart Failure Rats (p.961)
  • 1 Exercise Induced (p.966)
  • 2 Aortic Banding (p.966)
  • 3 Volume Overload (p.966)
  • 4 Thyroxine (p.967)
  • 5 Isoproterenol (p.967)
  • References (p.973)
  • 26 - Rat Models of Alcohol Use Disorder (p.986)
  • 1 Bottle Free-choice: Voluntary Oral Alcohol Intake and the Deprivation Effect (p.992)
  • 2 Continuous, Intermittent, and Limited Access Models (p.993)
  • 3 Alcohol Liquid Diet (p.993)
  • 4 Alcohol Vapor Exposure (p.993)
  • 1 Operant Alcohol Self-Administration (p.994)
  • 2 Progressive-Ratio Schedules of Reinforcement (p.995)
  • 3 Self-Administration Despite Punishment (p.995)
  • 4 Other Schedules of Reinforcement (p.995)
  • 5 Reinstatement of Alcohol Seeking (p.996)
  • 1 Conditioned Place Preference (p.998)
  • References (p.1000)
  • 27 - Rat Models of Obesity, Metabolic Syndrome, and Diabetes (p.1006)
  • 1 Single-Nutrition-Enriched Foods: Fat, Sucrose, and Fructose (p.1007)
  • 2 Dietary Variety: Cafeteria Diet (p.1007)
  • 1 Obese Zucker Rat (p.1008)
  • 2 Wistar-Kyoto Fatty Rat (p.1009)
  • 3 Obese Spontaneously Hypertensive Rat (p.1009)
  • 4 Otsuka Long-Evans Tokushima Fatty Rat (p.1009)
  • 1 The University of California Davis Type 2 Diabetes Mellitus Rat (p.1009)
  • 2 Obese Spontaneously Hypertensive Rat/Koletsky Rat (p.1009)
  • 3 Nile Grass Rat (p.1010)
  • 4 SHRSP Fatty (fa/fa) Rat (p.1010)
  • 5 Dahl S.Z-Lepr(fa)/Lepr(fa) Rat (p.1010)
  • 1 High-Fat Diet (p.1010)
  • 2 High-Sucrose/High Fat Diet (p.1010)
  • 3 High-Sucrose and High-Fructose Diets (p.1010)
  • 4 Cafeteria Diet (p.1011)
  • 1 Chemical Ablation Models of T1DM (p.1012)
  • 2 Models of Spontaneous T1DM (p.1012)
  • 3 Other Models of Induced T1DM (p.1013)
  • 1 Induced Models of T2DM (p.1014)
  • 2 Spontaneous Obese Models of T2DM (p.1014)
  • 3 Nonobese Models of T2DM (p.1015)
  • 1 Placental Insufficiency Models (p.1016)
  • 2 Models Involving Maternal and Fetal Malnutrition (p.1016)
  • References (p.1017)
  • 28 - The Rat in Neuroscience Research (p.1022)
  • 1 Brain Regions and Neurotransmitters Involved in Anxiety and Depression (p.1022)
  • 2 Behavioral Tests for Evaluating Anxiety and Depression (p.1023)
  • 3 Rat Models of Anxiety and Depression (p.1024)
  • 1 Brain Regions and Neurotransmitters Involved in PTSD (p.1025)
  • 2 Models of PTSD (p.1026)
  • 1 Intracerebroventricular Streptozotocin Injection (p.1028)
  • 2 Aluminum Chloride (p.1029)
  • 3 Aβ Intracerebral Infusions (p.1030)
  • 4 Adeno-Associated Virus Transduction With β-Amyloid Variants (p.1030)
  • 5 Transgenic Rat (TgF344-AD) (p.1030)
  • 6 Sex Differences in AD Pathology in Rats (p.1031)
  • 1 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (p.1031)
  • 2 6-Hydroxydopamine (p.1031)
  • 3 Rotenone (p.1031)
  • 4 Paraquat (p.1032)
  • 5 Sex Differences in Rat Models of PD (p.1032)
  • 1 Chemically Induced Inflammatory Pain (p.1034)
  • 2 Cancer-Induced Bone Pain (p.1034)
  • 3 Migraine (p.1035)
  • 4 Neuropathic Pain (p.1035)
  • 5 Osteoarthritis (p.1035)
  • 6 Visceral Pain (p.1035)
  • References (p.1036)
  • 29 - Rat Models of Central Nervous System Injury (p.1042)
  • 1 Contusion (p.1046)
  • 2 Compression (p.1049)
  • 3 Distraction and Dislocation (p.1051)
  • 4 Transection/Laceration (p.1052)
  • 5 Other Techniques (p.1054)
  • 1 Motor Function (p.1055)
  • 2 Sensory Testing and Neuropathic Pain (p.1057)
  • 3 Impact of Environmental Enrichment (p.1058)
  • 4 Electrophysiology (p.1058)
  • 5 Autonomic Testing (p.1059)
  • 6 Imaging (p.1060)
  • 7 Microscopic Tissue Analysis (p.1060)
  • 1 Preinjury (p.1061)
  • 2 Injury Procedure (p.1062)
  • 3 Postinjury (p.1063)
  • 1 Fluid Percussion Injury—Lateral and Midline (p.1066)
  • 2 Controlled Cortical Impact (p.1067)
  • 3 Penetrating (p.1068)
  • 4 Weight Drop (p.1069)
  • 5 Blast TBI (p.1070)
  • 6 Rotation (p.1071)
  • 1 Behavioral Tests (p.1072)
  • 1 Preinjury (p.1077)
  • 2 Injury Procedure (p.1077)
  • 3 Postinjury (p.1078)
  • 1 Caution in Interpreting Results from Rodent Studies and Extrapolating to Human Conditions (p.1078)
  • 2 Common Data Elements and Standardization of Practice in the Field (p.1079)
  • 3 Moving Forward: The Role of Rodent Models in CNS Trauma Research (p.1079)
  • References (p.1079)
  • 30 - Use of the Rat as a Model in Regenerative Medicine (p.1096)
  • 1 Surgical (p.1097)
  • 2 Chemical (p.1098)
  • 3 Genetic (p.1099)
  • 1 Recent Advances: Hepatocyte Transplantation (p.1099)
  • 2 Emerging Therapies (p.1100)
  • 1 Myocardial Infarction (p.1101)
  • 2 Congenital Defects (p.1101)
  • 1 Contusion (p.1105)
  • 2 Compression (p.1105)
  • 3 Transections (p.1105)
  • 4 Incomplete Transection (p.1105)
  • 5 Complete Transection (p.1105)
  • 1 Motor Training (p.1106)
  • 2 Electrical Epidural Stimulation (p.1107)
  • 3 Cell Therapy (p.1108)
  • 4 Biomaterials (p.1108)
  • 5 Future Directions (p.1108)
  • 1 Behavioral Alterations in the 6-OHDA Model (p.1110)
  • 1 Endochondral Ossification (p.1113)
  • 2 Intramembranous Ossification (p.1114)
  • References (p.1116)
  • 31 - Rat Models of Infectious Disease (p.1126)
  • 1 Arboviral Encephalitis: Flaviviruses in Infant Rats (p.1129)
  • 2 Rabies (p.1129)
  • 1 General Considerations (p.1133)
  • 2 Respiratory Syncytial Virus (p.1133)
  • 3 Influenza (p.1134)
  • 4 Metapneumovirus (p.1135)
  • 1 Contact Lens Keratitis (p.1141)
  • 2 Vascular and Soft Tissue Implants (p.1141)
  • 3 Periodontitis (p.1142)
  • 1 Oral and Invasive Candidiasis (p.1143)
  • 2 Hepatitis C and Hepatitis C-Like Viruses (p.1143)
  • 1 Pyelonephritis (p.1144)
  • 2 Epididymitis (p.1144)
  • 3 Prostatitis (p.1145)
  • 4 Vaginosis/Vaginitis (p.1145)
  • References (p.1147)
  • Index (p.1154)
  • ... and 822 more chapters

Frequently bought together

The Laboratory Rat 3Rd Edition
HK$840.00 HK$210.00
View full details

You may also like

1 of 6

Recently Added

1 of 4